HEPTAPHARMA, founded in 2018, is a burgeoning player in the pharmaceutical manufacturing sector, strategically located in Toluca, Mexico. Operating with a state-of-the-art facility spanning 3,400 m2, this enterprise specializes in producing an array of pharmaceutical forms. Its sophisticated systems focus primarily on injectables—liquid solutions, suspensions, emulsions, and lyophilized products—as well as solid capsules and liquid solutions, syrups, suspensions, and emulsions.
With a clear vision captured in its slogan, "Heptapharma es un complejo industrial que cuenta con 2,000m2 dedicados a la fabricación de diversas formas farmacéuticas", HEPTAPHARMA positions itself as a forward-thinking, innovation-driven entity in the competitive pharmaceutical landscape. Despite its promising operations, the company has yet to secure external investment, a detail that highlights potential growth opportunities for discerning investors.